Synapse - Works

Results (21)

Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancer

Journal Article

Mondaca, S.; Margolis, M.; Sanchez-Vega, F.; Jonsson, P.; Riches, J. C.; Ku, G. Y.; Hechtman, J. F.; Tuvy, Y.; Berger, M. F.; Shah, M. A.; more...
Gastric Cancer (2019)

Fulltext@MSK | Save

Multicenter prospective phase II trial of neoadjuvant dose-dense gemcitabine plus cisplatin in patients with muscle-invasive bladder cancer

Journal Article

Iyer, G.; Balar, A. V.; Milowsky, M. I.; Bochner, B. H.; Dalbagni, G.; Donat, S. M.; Herr, H. W.; Huang, W. C.; Taneja, S. S.; Woods, M.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Genetic predictors of response to systemic therapy in esophagogastric cancer

Journal Article

Janjigian, Y. Y.; Sanchez-Vega, F.; Jonsson, P.; Chatila, W. K.; Hechtman, J. F.; Ku, G. Y.; Riches, J. C.; Tuvy, Y.; Kundra, R.; Bouvier, N.; more...
Cancer Discovery (2018)

Fulltext@MSK | Save

Emergence of RTK/RAS/PI3K pathway alterations in trastuzumab-refractory HER2-positive esophagogastric (EG) tumors

Meeting Abstract

Janjigian, Y. Y.; Sanchez-Vega, F.; Tuvy, Y.; Bouvier, N.; Riches, J. C.; Margolis, M.; Millang, B. M.; Scott, S. N.; Kundra, R.; Castel, P.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Correlation of DNA damage response (DDR) gene alterations with response to neoadjuvant (neo) dose-dense gemcitabine and cisplatin (ddGC) in urothelial carcinoma (UC)

Meeting Abstract

Iyer, G.; Balar, A. V.; Milowsky, M. I.; Huang, W. C.; Woods, M.; Donat, S. M.; Herr, H. W.; Dalbagni, G.; Bochner, B. H.; Ostrovnaya, I.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Clinical next generation sequencing (NGS) of esophagogastric (EG) adenocarcinomas identifies distinct molecular signatures of response to HER2 inhibition, first-line 5FU/platinum and PD1/CTLA4 blockade

Meeting Abstract

Janjigian, Y. Y.; Sanchez-Vega, F.; Jonsson, P.; Tuvy, Y.; Bouvier, N.; Riches, J.; Kundra, R.; Ku, G.; Hechtman, J. F.; Kelsen, D.; more...
Annals of Oncology (2016)

Fulltext@MSK | Save

Multicenter prospective phase II trial of neoadjuvant (neo) dose dense gemcitabine and cisplatin (DD-GC) in patients (pts) with muscle-invasive bladder cancer (MIBC)

Meeting Abstract

Balar, A. V.; Iyer, G.; Milowsky, M. I.; Huang, W. C.; Woods, M.; Donat, S. M.; Herr, H. W.; Dalbagni, G.; Bochner, B. H.; Ostrovnaya, I.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Germline single nucleotide polymorphisms associated with response of urothelial carcinoma to platinum-based therapy: The role of the host

Journal Article

Gallagher, D. J.; Vijai, J.; Hamilton, R. J.; Ostrovnaya, I.; Iyer, G.; Garcia-Grossman, I. R.; Kim, P. H.; Przybylo, J. A.; Alanee, S.; Riches, J. C.; more...
Annals of Oncology (2013)

Fulltext@MSK | Save

Prognostic model for predicting survival of patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy

Journal Article

Apolo, A. B.; Ostrovnaya, I.; Halabi, S.; Iasonos, A.; Philips, G. K.; Rosenberg, J. E.; Riches, J.; Small, E. J.; Milowsky, M. I.; Bajorin, D. F.
JNCI: Journal of the National Cancer Institute (2013)

Fulltext@MSK | Save

Association of single-nucleotide polymorphisms in BCL2L1 and TACC3 with response to bacillus Calmette-Guerin intravesical therapy in non-muscle-invasive bladder cancer

Meeting Abstract

Alanee, S.; Gallagher, D. J.; Vijai, J.; Hamilton, R. J.; Ostrovnaya, I.; Garcia-Grossman, I. R.; Riches, J. C.; Regazzi, A. M.; Przybylo, J. A.; Gaudet, M.; more...
Journal of Clinical Oncology (2012)

Fulltext@MSK | Save